Navigation Links
Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients
Date:10/26/2009

ts with comorbidities; a reduction in the recovery time after the procedure; a decrease in the need for cardiopulmonary monitoring; and a significant reduction in cost.

"In Taiwan and many Asian countries, sedation is not routinely available and affordable, limiting the use of colonoscopic screening. When choosing between unsedated colonoscopy and sigmoidoscopy for screening, most patients undergo sigmoidoscopy because the majority of doctors and patients consider unsedated colonoscopy to be poorly accepted," said study lead author Hsiu-Po Wang, MD, National Taiwan University Hospital. "We compared patients who underwent either unsedated colonoscopy or sigmoidoscopy for primary colorectal cancer screening and found no significant differences in pain scores, patient acceptance, or need for sedation."

Patients and Methods

The prospective study was conducted from September 2006 to March 2007 by four experienced endoscopists at the Health Management Center of National Taiwan University Hospital. Patients who had not undergone previous sigmoidoscopy or colonoscopy were considered eligible and were asked to undergo either a sigmoidoscopy or colonoscopy without sedation. The choice of sigmoidoscopy or colonoscopy was at the discretion of the patient. A total of 261 (of approximately 1,400 eligible) patients participated in the study; 176 selected colonoscopy and 85 selected sigmoidoscopy. If the patient expressed intolerance of the unsedated examination, the patient could elect to stop the examination or receive sedation. All procedural variables, including biopsy (tissue sample), polypectomy (polyp removal), and other therapeutic procedures; time spent in the scope insertion phase; and total procedure time were recorded. To assess disparities in endoscopists' skill, insertion time was stratified by procedure type and was compared among the endoscopists.

Pain was evaluated by an 11-point visual analog scale from 0 to 10 (0: no pain
'/>"/>

Contact: Anne Brownsey
abrownsey@asge.org
630-570-5635
American Society for Gastrointestinal Endoscopy
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely
2. Wolves lose their predatory edge in mid-life, new U of Minnesota study shows
3. Study finds delay in follow-up among African-American women receiving abnormal breast finding
4. STAAR Surgical Collamer(R) Accommodating Study Team Reports First Phase Assessments at AAO
5. After Tonsillectomy, Short-Term Antibiotics Effective: Study
6. Study reveals an increase in long-term antidepressant drug use
7. Study Finds Less Toxic Treatment for Myeloma
8. CT Scans Surpass X-Rays for Swine Flu: Study
9. Study shows how normal cells influence tumor growth
10. Sex With a Partner Makes Evolutionary Sense: Study
11. Research partnership will study how electronic medical records can address genetics of drug safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... to artemisinin, the main drug to treat malaria, ... Plasmodium falciparum ( P. falciparum ) ... caused by a genetic mutation in the parasites. ... opposed to a standard three-day coursehas proved highly ... findings published today in the New England ...
(Date:7/30/2014)... Steven Reinberg HealthDay Reporter ... the United States, at least 2,000 Americans die from extreme ... Heat waves, heat stroke or sun stroke caused nearly ... and 2010, according to the U.S. Centers for Disease Control ... loss of body heat -- accounted for 63 percent of ...
(Date:7/30/2014)... News) -- It can happen in an instant: A small ... monitor and gets critically injured when the furniture tips over. ... look around their homes and imagine what could tip over, ... better than it becoming a reality," Dr. Alex Rosenau, president ... college news release. Between 2009 and 2011, roughly 43,000 ...
(Date:7/30/2014)... Hayward, CA (PRWEB) July 30, 2014 ... and accessories at the lowest prices on the internet ... Lightning Cables in two lengths and two colors. These ... performance standards. , The high quality SF Cable ... 8-pin connector with digital signal delivering faster charging and ...
(Date:7/30/2014)... York (PRWEB) July 30, 2014 The ... brain bleeding has filed a Xarelto lawsuit ( http://www.xareltolawsuitcenter.com/ ... blood thinner, Bernstein Liebhard LLP reports. According to the ... the District of Vermont on July 25th, the decedent ... he suffered an irreversible brain bleed that ultimately led ...
Breaking Medicine News(10 mins):Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 2Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 3Health News:Tip-Over Furniture Can Kill Kids 2Health News:SF Cable Delivers Certified Lightning Cable in Multiple Sizes and Colors 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3
... News) -- More than half of U.S. jails didn,t receive ... H1N1 swine flu, a new study says. Jail and ... diseases. The steady stream of new arrivals can introduce new ... it easy for diseases to spread, researchers from the U.S. ...
... have been linked to depression, according to UT Southwestern ... Study. It is believed to be the largest such ... already are associated with a cavalcade of health woes ... published in Mayo Clinic Proceedings ...
... , THURSDAY, Jan. 5 (HealthDay News) -- Toddlers who miss ... later in life, a new study indicates. Researchers looked ... that depriving them of a single daily nap resulted in ... problem-solving abilities. "Many young children today are not getting ...
... clinical trial found that rilonacept, an inhibitor of ... flares that occur when initiating uric acid-lowering therapy. ... IL-1 targeted therapy in prevention of gout flaresshow ... serious infections or treatment-related serious adverse events reported. ...
... vector-borne disease in the United States, with the majority of ... since the agent of the disease, the spirochete Borrelia ... However, the number of Lyme disease cases have steadily increased. ... of the Journal of Medical Entomology called "What ...
... Reporter , WEDNESDAY, Jan. 4 (HealthDay News) -- A vaccine ... severe liver damage and even liver cancer, might be possible ... , There is currently no vaccine for hepatitis C, which ... HIV, the hepatitis C virus mutates easily and has always ...
Cached Medicine News:Health News:Many Jails Got No Flu Shots During H1N1 Outbreak: CDC 2Health News:Low vitamin D levels linked to depression, UT Southwestern psychiatrists report 2Health News:Missed Naps Could Put Toddlers at Risk for Mood Disorders 2Health News:Clinical trial demonstrates that rilonacept significantly reduces gout flares 2Health News:Clinical trial demonstrates that rilonacept significantly reduces gout flares 3Health News:How can Lyme disease be prevented and controlled? 2Health News:Novel Hepatitis C Vaccine Shows Some Early Promise 2Health News:Novel Hepatitis C Vaccine Shows Some Early Promise 3
(Date:7/30/2014)... , July 30, 2014   Unique ... Groups Inc.: OTC Pink: UPZS), a Delaware Corporation, ... distribution agreement with Larasan Pharmaceutical Corporation ("Larasan"), a nature-based ... According to the agreement, US-based Larasan will work ... 6" frozen pizza through Larasan,s vast distribution network ...
(Date:7/30/2014)... 2014 Silicon Valley Bank, the bank of ... that examines the merger, acquisition and IPO activity ... to the annual report based on 2013 data, venture ... SVB started tracking the data in 2005. ... solid healthcare M&A activity over the last few years, ...
(Date:7/30/2014)...  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a ... expertise in opioid antagonists, announced today that it ... international research and development foundation. The ... initiatives, including those addressing health issues. Lightlake has ... of naloxone that could widely expand its availability ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3
... Fourth - Quarter 2010 Highlights ... Gross profit increased by 5.8% over Q4 FY09 to $8.8 ... $3.1 million with EPS of $0.13 Full Fiscal ... $115.0 million Gross Profit increased 23.7% YOY to $34.6 million ...
... Otonomy, Inc . announced today that David A. Weber, ... of the Board of Directors. Jay Lichter, Ph.D., managing director of ... continue to actively support the company as a member of the ... Dr. Weber to the Otonomy team, as his extensive experience in ...
Cached Medicine Technology:Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 2Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 3Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 4Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 5Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 6Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 7Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 8Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 9Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 10Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 11Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 12Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 13Winner Medical Reports Fourth Quarter and Fiscal 2010 Results 14Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer 2Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer 3
Molteno3 Glaucoma Drainage Device incorporates the latest advances from Professor Moltenos glaucoma research. It has been extensively tested since early 2004 and gives even better control of intraocu...
... 2.0 is a reagent and probe system ... The high throughput plate based system is ... provides a unique approach for RNA detection ... using branched DNA (bDNA) technology. Branched DNA ...
Cormet Hip Resurfacing is a conservative treatment for the young, active, high demand patient group which conserves femoral bone, provides anatomical bone loading, eliminates polyethylene and is desi...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Medicine Products: